Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Wegovy (also semaglutide, slightly different dosing) is FDA-approved for chronic weight management
FDA has a more rapid approach for approval of chronic weight management drugs, permitting short phase 3 trials of 52 to 68 weeks without requiring pre-approval cardiovascular outcomes trials (CVOTs) whereas Europe insists on such trials
FDA-Approved Indications at a Glance Table 3
Clinical efficacy depends on the active compound, not the manufacturer
US$ 26.29
US$ 26.08
US$ 24.15
US$ 23.84
US$ 25.98
US$ 29.06
US$ 21.34
US$ 22.73
